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PENETRATION OF RADIOIODIDE (1131) THROUGH HUMAN SKIN*
.1. TAS, M.D. AND Y. FEIGE, M.Sc., PuD
Investigations on the penetration of electro -
lytes through the human skin, using chemical and
spectroscopic technics, have so far yielded con-
flicting results. Most authors found no evidence
of penetration of electrolytes, and whilst several
workers claim to have detected the passage of
iodides and chlorides this has been denied by
others (1, 2, 3, 4, 5, 6, 7).
A new approach to this problem has been
stimulated by the advent of more sensitive and
simply applied methods utilizing radioisotopes.
In the present study the absorption of radioiodide
from the skin into the body fluids is investigated.
In addition to the theoretical interest of the
penetrability of the skin, these examinations have
also a practical aspect, considering the wide-
spread use of radioactive iodine in medicine, and
the possible contamination of the hands, espe-
cially the palms by the radioactive material.
The skin of the forearm and of the palmar skin
of the hand were investigated separately.
MATERIAL AND METHODS
lRadioiodide (1131) was chosen for this study
because of its easy identification as a gamma-ray
emitter, its relatively short half-life of 8 days, its
lack of toxicity, and because of its well estab-
lished metabolic pathways. Forty-eight hours
after the ingestion of a tracer dose of J131 almost
100 per cent can be accounted for by the amounts
detected in the thyroid gland and urine, now a
standard procedure in the assessment of thyroid
function.
The isotope was obtained from the Radio-
chemical Centre, Amersham, England, as carrier-
free iodide (liD) in a weak sodium sulphate solu-
tion of pH 8—10. The specific activity was about
10 curies per mg iodine, and the concentration
about 50 mc per cc.
This solution was diluted with distilled water
to about 0.5—1.0 mc P3' per cc, and about 0.1
gamma of NaI'27 per cc was added as a carrier for
the radioiodide. Thirty two patients of the der-
matological ward co-operated voluntarily as test
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subjects. They were divided in two groups. One
group of 24 was tested on the inner side of the
forearm, another group, comprising 4 subjects of
the former group and 8 additional patients, was
tested on the palmar skin. 0.2 cc of the solution,
containing 200 pc of 3i was dripped on a 4 x 4 cm
cotton cloth patch and applied to the skin which
was not cleaned beforehand. Only patients whose
entire upper extremity was free of lesions were
chosen. The patch was covered with a film of
plastic material and secured by adhesive tape.
A firm gauze bandage was applied, with the aim
of preventing leakage through the edges of the
adhesive tape.
Each patient collected the urine of the first and
second 24 hours into two separate bottles. Ap-
proximately twenty four hours after application,
the patch, which was still wet, was removed and
the skin washed with soap-solution, alcohol, and
benzin (2 strokes with each fluid). The patch, the
wash fluids, and the cotton-wool used were ex-
amined for radioactivity using a Geiger-Mueller
tube and a standard solution of J131 for com-
parison. The radioactivity remaining on the skin
after the washing, and again approximately 24
hours later, was measured with the tested skin
25 cm from the tube. After the washing, the skin
was covered with a gauze bandage for the final 24
hours to prevent traces of 1131 from reaching the
mouth and being thus absorbed. The I1 in the
thyroid was also measured after approximately
24 and 48 hours, the treated skin area being care-
fully shielded from the Geiger detector. The urine
samples were measured by immersion of a counter
into 1 liter of the fluid.
The measurements of the amount of radioiodide
in the patch, wash fluids, and skin were accurate
to about 3 per cent of the dose applied. The
measurements over the thyroid and in the urine,
being more relevant to the interpretation of the
experiment, were performed more precisely, the
accuracy attained being about 0.2 per cent of the
dose given in the former and about 0.05 per cent
in the latter.
RESULTS
On the average about 2 per cent of the dose
applied to the forearm entered the blood circula-
tion during the first 24 hours, as shown by the
figures summarizing the thyroid and urine deter-
minations in Table I. The amount remaining at
the skin site did not alter appreciably in the
second 24 hours, and therefore did not penetrate,
Penetration of f151 in 12 Subjects through the Palmer Skin
The figures express the percentage of the applied dose
Sex Age 24 hours
.
Washing Palm
24 hours 48 hours
Thy
24 hours
roid
48 hours
Ur
24 hours
joe
48 hours
Recovery
1 1 13 51 19 32.5 31.6 0.15 0.19 0.17 0.07 102
2 f 28 74 16 6.1 4.4 0.34 0.37 0.23 0.18 96
3 m 21 66 18.5 13.4 10.8 0 0.56 0.37 0.11 99
4 in 45 68 15.6 10.4 12.6 0.1 0 0.60 0.20 96
5 in 56 61 28.5 16.2 5.0 0.4 0.0 0.16 0.06 101
6 m 50 58 — 33 25 0.4 0.6 0.46 0.14 —
7 in 60 75 17 10.8 11 0.23 0.64 0.48 0.30 104
8 in 67 78 13.1 — 0.4 0.22 0.34 0.26 0.16 92
9 1 31 55 12.2 32.3 31.5 0.11 0.40 0.48 0.12 100
10 1 11 64 18.2 14.8 13.7 0.2 0.22 0.12 0.06 96
11 f 55 67 18.2 5.1 4.1 0.33 0.21 0.44 0.13 91
12 f 23 69 21.5 11 8.4 0.46 0.1 0.21 0.08 101
Mean
values
Standard
error
65.5 18.0 17.2 13.2 0.245 0.302 0.332 0.134 98
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TABLE I
Penetration of I's' Through the Skin of the Forearm in 24 Subjects
The figures express the percentage of the applied dose
Arm Thyroid UrineCase
No. Sex Age
Patch
24 hours
1 f 13 75
2 f 28 74
3 in 21 78
4 m 45 67
5 m 36 81
6 m 66 69
7 in 18 63
8 m 26 71
9 in 50 80
10 m 47 84
11 m 49 72
12 in 44 85
13 1 18 82
14 f 30 —
15 f 61 84
16 f 14 75
17 f 11 75
18 f 25 71
19 f 26 75
20 1 43 53
21 f 62 82
22 1 15 77
23 f 45 67
24 1 20 69
Mean
values
Standard
error
Washing
24 hours
11.8
12.5
12.8
16.4
10.5
7.5
28
14.4
10
9.3
13
11
14.8
13.8
7.3
15.7
17.3
15
19
18
14.6
8.3
13.1
8.9
13.5
24 hours
4.6
7.5
2.9
14.4
2.6
14.8
7.1
10.8
12
7.7
4.7
4.7
12
4.9
4.9
6.0
1.8
1.5
17.4
1.9
9.7
4.7
13.6
7.5
24 hours
0.1
0.3
0
0.7
0.2
0.5
1.2
0.3
0.1
1.4
0.5
0.2
0.8
0.1
0.8
0.7
0.2
1.0
1.9
0.7
0.9
0.4
0
48 hours
4.5
6.8
1.8
14.9
1.6
10.5
5.7
11.0
11
8.1
4.2
4.7
14.6
5.0
4.2
5.6
1.9
1.4
14.6
1.8
4.9
12,5
6.9
48 hours
0.1
0.2
0.4
1.0
0.2
0.1
1.6
0.6
0.2
1.3
0.4
0.3
0.1
1.4
0.0
0.9
1.4
0.25
1.2
2.0
0.4
0.9
0.2
0
24 hours
3.1
0.25
0.7
0.65
1.5
0.7
2.2
0.45
0.6
2.0
0.66
0.54
0.55
0.64
0.10
3.2
1.9
2.6
1.4
1.7
0.8
0.6
2.0
0.55
1.22
0.2
0.5
0.5
0.9
1.0
0.11
0.27
0.60
0.12
1.3
1.3
0.7
0.3
0.63
0.14
0.25
1.2
0.50
0.55
Recovery
95
94
93
100
96
91
101
98
103
105
92
102
102
97
101
102
91
98
91
100
97
88
92
96.974.3 0.02 0.69
±1.1
TABLE II
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but probably remained in the superficial layers
or in the appendages. About 3.1 per cent on the
average of the dose was unaccounted for.
As shown in Table II, about 0.3 per cent of
the radioiodide applied to the palmar skin was
detected in the thyroid gland after 48 hours,
and a total of about 0.46 per cent in the two
urine samples. The amount penetrating the pal-
mar skin was thus very small, being about one
third of that absorbed through the skin of the
forearm. Patients 1—4 in both tables were the
same subjects, thus excluding in these cases
factors depending on individual variation. At
least one month elapsed between experiments
performed on the same individual, to obviate
any interference from the first application of
radioiodide.
The rather large variations about the mean
values in both tables are probably due to the
many individual factors involved in such experi-
ments. Due to the small number of subjects
tested no attempt was made to correlate the
results with sex, age, or seasonal differences.
Although eleven of the subjects were receiving
ACTH and/or cortisone this did not seem to
affect the penetration of the iodide.
DISCUSSION
The radioactivity detected in the thyroid gland
and urine was taken as the only proof that iodide
had actually penetrated the skin into the body
fluids. The other measurements were comple-
mentary only, assuring the maximal recovery of
the applied dose. Any unaccounted for fraction
of the dose might have been due to an accumula-
tion of errors in the various measurements. It is
possible that the actual amount of radioiodide
excreted in the urine was even greater, for per-
haps occasional specimens were not collected.
This was certainly true for those patients showing
a higher J131 excretion value in the second 24 hours
period e.g. cases 11, 15 of Table I, for it is well
known from tracer studies of thyroid function
that the second day's excretion of radioiodide is
much less than in the first 24 hours.
Of the electrolytes, radioactive Na was found
by Johnston and Lee (8) to penetrate the intact
human skin. They used aqueous solutions incor-
porated in different ointment bases, which were
rubbed into the skin. Rothman (3), however,
suggested that the mechanical factor of pressing
the ointments into the skin might be responsible
for the absorption.
Witten et al. (9) using ointment, lacquer and
an alcoholic solution, proved the penetration of
thorium X into the epidermis, hair follicles,
sweat ducts and glands. Although it was found
that the thorium salt (a chloride) was dissolved
in small water droplets in the lacquer—and
possibly also in the ointment—these experiments
are not irrefutable proof of the penetration of
electrolytes from a watery solution. In a study
on radioactive 32 Witten and co-workers (10)
using an aqueous solution of sodium phosphate.
found penetration of 32 into the same loci as in
the experiments with thorium X.
The above mentioned investigations were
based on measurement of the radioactivity on the
skin or its localization within the skin. They did
not demonstrate the presence of radioactive sub-
stances in an internal organ, or in the body fluids
or excretions.
Miller and Selle (6) were unable to detect the
absorption of an aqueous solution of radioactive
NaP3' in one human subject. Mali and Woidring
(7) did not find radioactivity in the skin and the
venous blood after application of NaI'31.
En a small number of preliminary experiments
we dripped a solution of J131 onto the unprepared
skin of the forearm, gently spread it with a glass
rod, and allowed it to dry. Traces of radioiodide
were absorbed as demonstrated by the appear-
ance of radioactivity in the urine. The patch test
technic was then introduced to try to increase
iodide penetration. This technique, however,
does not simulate normal physiological condi-
tions, since maceration of the epidermis occurs.
Furthermore the ionizing effect of the radiation
on the cells might increase penetration.
The finding that measurable amounts of iodide
penetrated the palmar skin from a watery solu-
tion is of interest considering the absence of hair
follicles. MacKee, Sulzbergcr, Herrmann and
Baer (11) found no penetration of dyes through
the palms, and Shelley and Melton (12) found no
reaction to histamine on the palmar as contrasted
with the glabrous skin. Herrmann (13) failed to
elicit positive skin tests in hypersensitive in-
dividuals by inunction of protein-allergens to-
gether with "Intraderm", although he used very
energetic methods. On the other hand Waizer
and Sack (14) described positive reactions to
cotton seed absorbed through the palms of
individuals passively sensitized to this antigen.
They used mechanical force for the inunction.
It is interesting to note that whereas 74.3 per
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cent of the applied dose of radioiodide on the
forearms remained in the patch, only 65.5 per
cent was found on the patch after removal from
the palmar skin. A greater amount of radio-
activity was found after 24 hours on the palm:
17.2 per cent than on the arm: 7.5 per cent. (After
48 hours the amounts were 13.2 per cent and 6.9
per cent respectively.) Both findings might per-
haps be explained by the assumption that a
sizable amount of iodide was absorbed in the
thick corneal layer of the palm, without being
able to penetrate the skin barrier. This does not
explain the diminished penetration of radioiodide
through the palmar skin, since the corneal layer
is not known to be a barrier to penetration (Roth-
man (3)). The absence of hair follicles has to be
taken into account in explaining the diminished
penetration.
Cautious interpretation should be made of the
finding that a small percentage of the radiodide
was absorbed through the skin. Whether iodine
penetrates the skin in the form of the iodide ion
(Ij or whether as molecular iodine (II) as sug-
gested by Rothman (3) is uncertain. With a pH
higher than 7 no conversion to molecular iodine
will occur. However, since human sweat is acid,
some radiodide might be oxidized to molecular
iodine at the sweat ducts, and be absorbed in
that form.
From the practical point of view it may be
noted that it is not enough to prevent ingestion
and inhalation of radioiodide. If the skin is con-
taminated a considerable percentage remains in
the superficial skin layers and is a source of beta
and gamma radiation. Moreover small amounts
penetrate the skin and are concentrated in the
thyroid gland.
SUMMARy
The ability of radioactive iodide (1131) to pene-
trate the skin was tested, using a patch test tech-
nic. One group of subjects was tested on the fore-
arm, the other on the palmar skin.
About 2 per cent of the 1131 applied to the fore-
arm passed the skin barrier and was detected in
the thyroid and the urine.
Penetration of radioactive iodide through the
palmar skin was also demonstrated, being about a
third of the penetration through the skin of the
forearm.
Radioiodide simply dropped on the skin and
allowed to dry penetrated in traces.
About 7 per cent of the dose applied to the
forearm and about 13 per cent of the dose on the
palm remained in the superficial layers of the
skin for a period of at least 48 hours.
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